Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Aidence logo — AI-powered clinical applications for the lung cancer pathway...

Aidence

AI-powered clinical applications for the lung cancer pathway

Founded 2015 The Netherlands The Netherlands 13 employees Acquired Total: $14.21M AI, Health Care +1

General Information

Company Name Aidence
Founded Year 2015
Location The Netherlands The Netherlands
Founders / Decision Makers
Team member
Employees 13
Industries AI, Health Care, Information Technology
Funding Stage Acquired
Business Model B2B, SaaS
Revenue Model Subscription, Usage Based, Service Fee
Offices as of Aug 2026
Amsterdam, The Netherlands
Social

BounceWatch is an independent company data service, not affiliated with Aidence. To contact Aidence, visit aidence.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Aidence compare?

A PDF of Aidence and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Aidence soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

AI Insight

Bounce Watch AI
1 month ago

Aidence completed a significant strategic shift with its acquisition by RadNet in January 2022, integrating its AI-powered lung cancer diagnostics into a leading US diagnostic imaging provider. A recent highlight indicating a substantial website update suggests ongoing dynamic changes, likely reflecting post-acquisition integration efforts, potential rebranding, or an expansion of its CE-certified Veye Lung Nodules solution within RadNet's broader ecosystem. This strategic evolution positions Aidence for enhanced market reach and continued innovation under new ownership.

Signal Types
Acquisition Product Strategic Shift
Strategic Labels
Post-Acquisition Integration AI Healthcare Growth Digital Presence Update
Next Move: Product Update
·
Impact: 8/10
·
Ideal For: M&A Analysts — Healthcare AI

About Aidence

Aidence, founded in 2015, specializes in AI-powered clinical applications for the lung cancer pathway. Based in The Netherlands, the company operates at the intersection of AI, Health Care, and Information Technology. Recognizing the transformative potential of data, Aidence is committed to enhancing disease prevention, management, and treatment through state-of-the-art AI solutions.

Its flagship product, Veye Lung Nodules, is a CE certified tool currently facilitating pulmonary nodule management and lung cancer screening across Europe. This solution aims to improve patient outcomes by accelerating diagnostics, minimizing misdiagnosis risks, and aiding in the early detection of lung cancer.

Since joining the AI division of RadNet—a major US provider of diagnostic imaging services—through an acquisition investment on 01 January 2022, Aidence is well-positioned for expansion. Investors should note the strategic significance of Aidence's integration into RadNet as it aligns with a commitment to revolutionize healthcare delivery using AI.

Business keywords: AI-powered clinical applications, lung cancer pathway, data-driven disease management, pulmonary nodule management, CE certified solutions, early-stage lung cancer detection, diagnostic imaging services, healthcare AI solutions, clinical workflow integration, medical diagnostics, AI for healthcare professionals, predictive analytics in healthcare, radiology AI solutions, computer aided diagnostics, deep learning in medical imaging

Services & Products

Enterprise Imaging
Diagnostic Suite
Operations Suite
TechLive
Reporting Pro
Population Health Solutions

Target Customers

Radiologists Healthcare Institutions Diagnostic Centers Clinicians Medical Practitioners

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Acquisition Undisclosed 1
RadNet
01 Jan 2022
Grant $1.91M 1
European Innovation Council
European Innovation Council
01 Mar 2020
Series A €10.00M 6
Northzone henQ Rabo Frontier Ventures
Northzone, henQ +4
01 Feb 2019
Seed €2.30M 3
Northzone henQ Health Innovations
Northzone, henQ +1
01 Jun 2017
Seed Undisclosed 1
Health Venture
Health Venture
01 Nov 2015

Aidence Alternatives & Competitors

View All Alternatives
Aidence vs
contextflow
contextflow Austria

Supporting physicians in the diagnosis of lung conditions with comprehensive structural + functional...

Series A
31 employees
AI, Big Data
Compare Aidence vs contextflow
Aidence vs
Sycai Medical
Sycai Medical Spain

The only AI-based multiorgan product for early diagnosis and non-invasive monitoring of abdominal ca...

Grant
22 employees
AI, Health Care
Aidence vs
Hevi AI
Hevi AI Turkey

An Artificial Intelligence Company based on Computer Vision, Medical Image Analysis

Seed
29 employees
AI, Health Care
Also compare with: Aidence vs 深睿医疗Deepwise 深睿医疗Deepwise View all alternatives

FAQ About Aidence

AI-powered clinical applications for the lung cancer pathway
Aidence was founded in 2015.
Aidence is headquartered in The Netherlands. As of Aug 2026, it also has offices in Amsterdam, The Netherlands.
Aidence operates in AI, Health Care and Information Technology. Its work centres on AI-powered clinical applications, lung cancer pathway, data-driven disease management and pulmonary nodule management. Its customers include Radiologists, Healthcare Institutions and Diagnostic Centers.
Aidence has a B2B and SaaS business model. Its revenue comes from Subscription, Usage Based and Service Fee.
Aidence has approximately 13 employees.
Aidence has completed 5 funding rounds, raising a total of $14.21M. The latest funding stage is Acquired.
Aidence offers: Enterprise Imaging, Diagnostic Suite, Operations Suite, TechLive, Reporting Pro, Population Health Solutions.
Top alternatives and competitors to Aidence include contextflow, Sycai Medical, Hevi AI, Clairity, Inc., Ligence. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Aidence and contextflow are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Aidence, https://bouncewatch.com/company/aidence, updated 24 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes